Applying new diagnostic criteria for acute kidney injury to facilitate early identification of nephrotoxicity in vancomycin-treated patients

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 7, 2011, Pages 3278-3283

  Minejima, Emi ^a,b   Choi, Joyce ^b   Beringer, Paul ^b   Lou, Mimi ^b   Tse, Edmund ^a   Wong Beringer, Annie ^a  

^a HUNTINGTON MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE FACTOR; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY INJURY NETWORK; AGED; ARTICLE; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROTOXICITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; CREATININE; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VANCOMYCIN;

EID: 79959238061     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00173-11     Document Type: Article

References (14)

1. Bellomo, R., C. Ronco, J. A. Kellum, R. L. Mehta, and P. Palevsky. 2004. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 8:R204-R212.
2. Coca, S. G., B. Yusuf, M. G. Shlipak, A. X. Garg, and C. R. Parikh. 2009. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 53:961-973.
3. Cruz, D. N., Z. Ricci, and C. Ronco. 2009. Clinical review: RIFLE and AKIN - time for reappraisal. Crit. Care 13:211.
4. Dieterich, C., et al. 2009. Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates. Toxicol. Sci. 107:258-269.
5. Hazlewood, K. A., S. D. Brouse, W. D. Pitcher, and R. G. Hall. 2010. Vancomycin-associated nephrotoxicity: grave concern or death by character assassination? Am. J. Med. 123:182.e1-182.37.
6. Hidayat, L. K., D. I. Hsu, R. Quist, K. A. Shriner, and A. Wong-Beringer. 2006. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch. Intern. Med. 166: 2138-2144.
7. Hutschala, D., et al. 2009. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion. Anesthesiology 111:356-365.
8. Jeffres, M. N., W. Isakow, J. A. Doherty, S. T. Micek, and M. H. Kollef. 2007. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin. Ther. 29:1107-1115.
9. Mehta, R. L., et al. 2007. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit. Care 11:R31.
10. Rybak, M., et al. 2009. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am. J. Health Syst. Pharm. 66:82-98.
11. Soni, S. S., C. Ronco, N. Katz, and D. N. Cruz. 2009. Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif. 28: 165-174.
12. Stevens, L. A., et al. 2010. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 ml/min/1.73 m2. Am. J. Kidney Dis. 56:486-495.
13. Vaidya, V. S., M. A. Ferguson, and J. V. Bonventre. 2008. Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 48:463-493.
14. Wong-Beringer, A., J. Joo, E. Tse, and P. Beringer. 2011. Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy. Int. J. Antimicrob. Agents 37:95-101.